Two specialists are impressed by the preliminary findings of a randomized trial in newly diagnosed patients, but another is ...

Biotechnology is at the forefront of innovation, transforming healthcare and pushing the boundaries of what’s possible. As groundbreaking discoveries unfold daily—from cutting-edge therapies to ...

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other biotech stocks. As we have mentioned in our article, “10 Best Penny Stocks to ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ ... Currently, more than 450 life sciences companies, classified as “startups” or “scaleups,” are actively ...

Caption: Frame Stock Footage via Shutterstock. A trial studying a higher dose of Biogen’s spinal muscular atrophy (SMA) drug Spinraza (nusinersen) has met the primary endpoint in a cohort of infants ...

Amgen is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Biogen Inc. (BIIB), a stock from the same industry, has gained 2.6%. The company reported its results ...

We expect an in-line return from the stock in the next few months. Amgen is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Biogen Inc. (BIIB), a stock from the same ...